ReviewBritish journal of clinical pharmacology1994
Clinical pharmacology, physiology and pathophysiology of superficial veins--2.
Review in British journal of clinical pharmacology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo.Clinical and experimental hypertension (New York, N.Y. : 1993) · 2010Trial
- Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins.British journal of clinical pharmacology · 1999Trial
- The effects of age on human venous responsiveness to neuropeptide Y.British journal of clinical pharmacology · 1999Trial
- Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline.Naunyn-Schmiedeberg's archives of pharmacology · 1996Trial
- Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.British journal of clinical pharmacology · 1995Trial
- An investigation into the direct and indirect venoconstrictor effects of endothelin-1 and big endothelin-1 in man.British journal of clinical pharmacology · 1995Trial
- Scientific Papers and Patents on Substances with Unproven Effects. Part 2.Recent patents on drug delivery & formulation · 2019Review
- A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction.Pharmacogenetics and genomics · 2013Article
- Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo.Journal of hypertension · 2011Article
- Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.Journal of hypertension · 2010Article
- Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans.Circulation · 2008Article
- Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients?Journal of clinical hypertension (Greenwich, Conn.) · 2007Article
- Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications.British journal of clinical pharmacology · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.